Home > Publications database > A plain language summary of the preliminary results for encorafenib plus binimetinib and pembrolizumab in adults with BRAF V600-mutant melanoma in the STARBOARD study.
 
Journal Article DKFZ-2025-00934
http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
A plain language summary of the preliminary results for encorafenib plus binimetinib and pembrolizumab in adults with BRAF V600-mutant melanoma in the STARBOARD study.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2025
Taylor & Francis London

Future oncology 21(12), 1445-1455 () [10.1080/14796694.2025.2488226]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Classification:

Note: 2025 May;21(12):1445-1455
Contributing Institute(s):
  1. DKTK Koordinierungsstelle Essen/Düsseldorf (ED01)
Research Program(s):
  1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2025
Database coverage:
Medline ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Essential Science Indicators ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database
 Record created 2025-05-08, last modified 2025-05-25
Similar records



Rate this document:

Rate this document:
1
2
3
4
5
 
(Not yet reviewed)
DKFZ :: Search :: Submit :: Personalize :: Help
Powered by Invenio 1.1.7-dirty
Maintained by zb.invenio@dkfz-heidelberg.de

Impressum | Data Privacy Policy